Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Reminder - NIH Natural Disaster Policy - Hurricane Dorian

(NOT-OD-19-143) National Institutes of Health

General Notices

Notice of Pre-Application Webinar for FOAs related to the NHLBI CATALYZE Program: RFA-HL-20-022, RFA-HL-20-023, RFA-HL-20-024, RFA-HL-20-027 and RFA-HL-20-028

(NOT-HL-19-709) National Heart, Lung, and Blood Institute

New to Working with the NIH Grants Process & Policies? Dont Miss the NIH Regional Seminar on Program Funding and Grants Administration Phoenix, AZ Nov. 6-8, 2019

(NOT-OD-19-144) National Institutes of Health

Request for Information (RFI): Inviting comments and suggestions on the development of a prize competition for Gender Diversity in the Biomedical Research Workforce

(NOT-OD-19-141) Office of Research on Women's Health

Funding Opportunities

Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)

(PAR-19-375) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Cancer Institute

National Heart, Lung, and Blood Institute

National Institute of Dental and Craniofacial Research

Application Receipt Date(s): Standard dates apply , The first standard application due date for this FOA is February 16, 2020.

Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)

(RFA-HL-20-006) National Heart, Lung, and Blood Institute

National Cancer Institute

National Institute on Aging

National Institute of Allergy and Infectious Diseases

Application Receipt Date(s): November 18, 2019; October 15, 2020; October 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

(RFA-HL-20-022) National Heart, Lung, and Blood Institute

Application Receipt Date(s): November 8, 2019, March 9, 2020, July 9, 2020, March 9, 2021, July 9, 2021

Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

(RFA-HL-20-023) National Heart, Lung, and Blood Institute

Application Receipt Date(s): November 8, 2019, March 9, 2020, July 9, 2020, March 9, 2021, July 9, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) (RFA-HL-20-024) National Heart, Lung, and Blood Institute Application Receipt Date(s): November 8, 2019, March 9, 2020, March 9, 2021, July 9, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)

(RFA-HL-20-027) National Heart, Lung, and Blood Institute

Application Receipt Date(s): November 8, 2019, March 9, 2020, July 9, 2020, March 9, 2021, July 9, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) (RFA-HL-20-028)

National Heart, Lung, and Blood Institute Application Receipt Date(s): November 8, 2019, March 9, 2020, March 9, 2021, July 9, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Bench to Bassinet Program Administrative Coordinating Center (U01 - Clinical Trial Not Allowed) (RFA-HL-21-002) National Heart, Lung, and Blood Institute

Application Receipt Date(s): March 6, 2020